Wasfi Al-Azzam

Dr. Wasfi Al-Azzam is an Associate Fellow at GlaxoSmithKline. He established Biopharm products’ higher order structure (HOS) characterization capability at GlaxoSmithKline including facilities for forced degradation studies and for particles characterization and quantification. He has supported various early and late stage projects. His efforts in product characterization, downstream process development support, and addressing regulatory requirements directly contributed to successful launching of 3 products into markets. Al-Azzam is one of the pioneers who established the concept of Biopharm HOS quality attributes. Wasfi Al-Azzam is well established with networks from industrial, academic, and regulatory institutions around the world. He served the scientific and pharmaceutical communities via several peer reviewed publications and as invited speaker at various conferences. Dr. Al-Azzam is the founder of the international symposium of Higher Order Structure of protein therapeutics, which he chaired and still part of the organization committee.
Wasfi is currently leading several matrix teams developing various products at early and late stages. Dr. Al-Azzam gained unique skill by leading the CMC development of Biopharm assets into Immuno PET programs. He is also part of Advance manufacturing team developing various PAT technologies to support manufacturing.
Wasfi speaks English, Arabic, Turkish, and Spanish. He likes to travel and cook in his free time.